Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 96
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Next Generation Non-Seeing Eye Prosthesis

    This project aims to push the current state of the art in ocular prothestics by integrating a small system...

    Developing a new tissue preservation method inspired by Tardigrades

    There are two routine ways to preserve tissues: formalin-fixed paraffin-embedded preservation (FFPE) and...

    How does taking Ritalin affect depersonalization-derealization disorder patients?

    We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

    Backer Badge Funded